1.
J Eur Acad Dermatol Venereol
; 35(12): e857-e859, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1429875
Subject(s)
COVID-19 , Psoriasis , COVID-19 Vaccines , Humans , SARS-CoV-2 , Vaccination/adverse effects
2.
Clin Exp Dermatol
; 47(1): 157-158, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1373804
ABSTRACT
Several individuals have developed delayed localized cutaneous vaccine reactions to the two novel mRNA Covid-19 vaccines. Clinical and histopathologic results of this case series study confirm that the localized injection-site reactions to the mRNA COVID-19 vaccines are delayed hypersensitivity reactions that, unlike immediate hypersensitivity reactions, are not a contraindication to vaccination.
Subject(s)
2019-nCoV Vaccine mRNA-1273/adverse effects , COVID-19/prevention & control , Drug Hypersensitivity/etiology , Hypersensitivity, Delayed/chemically induced , Injection Site Reaction/etiology , Adult , Aged , Aged, 80 and over , Drug Hypersensitivity/pathology , Female , Humans , Hypersensitivity, Delayed/pathology , Male , Middle Aged , Retrospective Studies , SARS-CoV-2
3.
Br J Dermatol
; 185(1): 209-210, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1199647
Subject(s)
COVID-19 , Psoriasis , Skin Diseases , COVID-19 Vaccines , Humans , Intention , Psoriasis/drug therapy , SARS-CoV-2 , Vaccination
4.
J Eur Acad Dermatol Venereol
; 35(8): e507-e509, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1138165
5.
J Eur Acad Dermatol Venereol
; 34(11): e673-e675, 2020 Nov.
Article
in English
| MEDLINE | ID: covidwho-607921